Lumida
/XPER
⌘K
Xperi Inc

Xperi Inc

XPER
$5.88USD↑+2.98%+0.17 today

MARKET CAP

286.8M

P/E (TTM)

5.5x

FWD P/E

6.1x

DAY RANGE

$6 – $6

52W RANGE

$5
$9

AI Summary

Stalk
TrimMedium

XPER is locked in a Stage 3 downtrend under declining EMAs with persistent lower highs and lower lows. Momentum remains decisively negative and price is oversold without signs of stabilization or reversal. We maintain a medium- and long-term bearish stance and defer further selling until price rallies into the 9-/20-/50-day EMA cluster for a rejection. A reclaim and hold above that zone would be required to shift the bias.

  • ↑IP licensing revenue rose 41% YoY to $139M in Q1
  • ↑FY22 revenue guidance boosted to $930–960M on strong license deals
  • ↓Profitability factors remain weak, pressuring margins amid product softness
Full analysis →

Buying

6

institutions

Selling

3

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY4.04 M33.25 M+77.29 K+49.8%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL509.98 K4.20 M+-40.20 K+36.2%0.01%
JC

Jpmorgan Chase & Co

Q2 2026

SELL494.27 K4.08 M+-10.95 K+45.4%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY452.85 K3.73 M+2.00 K+47.6%0.00%
MM

Millennium Management LLC

Q2 2026

BUY307.75 K2.53 M+37.32 K+67.3%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL129.74 K1.07 M+-180.06 K-38.5%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUYNEW86.69 K713.49 K+86.69 K+0.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW14.30 K117.66 K+14.30 K+0.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY1.66 K13.64 K+968.00+253.1%0.00%